Castle Biosciences (CSTL) has received approval for the dual listing of its common stock on Nasdaq Texas, in addition to its primary listing on the Nasdaq Global Market, the company said Monday.
Castle Biosciences' shares will start trading on Nasdaq Texas on Monday under the ticker "CSTL," according to the statement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.